查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589610

干眼症市场：依药物、产品分类 - 全球预测 2025-2030

Dry Eye Syndrome Market by Drug (Anti-inflammatory Drugs, Autologous Serum Eye Drops, Lubricant Eye Drops), Product (Eye Ointment, Gel, Liquid Drops) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

干眼症市场2023年估值为43.9亿美元，预计到2024年将达到47.1亿美元，复合年增长率为7.21%，到2030年预计将达到71.6亿美元。

干眼症（DES）是一种多因素疾病，其特征是泪液数量或品质缺乏，导致眼表发炎和损伤。干眼症市场包括旨在减轻症状和提高患者生活品质的诊断方法、药物、设备和替代疗法。由于人口老化、生活方式的改变和长时间接触数位萤幕，全球盛行率不断增加，对有效管理方案的需求变得越来越重要。最终用途范围从人工泪液和复合药物到穿刺塞和程序解决方案等医疗设备，服务消费者和临床环境。关键的成长要素包括公众对眼睛健康意识的提高、诊断技术的进步以及监管部门对新疗法的核准迅速增加。最新的机会在于使用远端医疗进行远距离诊断和护理、个人化医疗方法的开拓以及未确诊人群新兴市场的扩张。要利用这些优势，就需要对研发进行投资，与高科技公司合作以实现创新的交付机制，以及扩大进入范围的策略定价模式。该市场面临着巨大的潜力、严格的监管要求、高昂的研究成本以及管理与新疗法相关的副作用等挑战。此外，已开发国家的市场饱和和患者违规从也是主要障碍。对于寻求创新的公司来说，探索非侵入性诊断工具、人工智慧主导的患者管理系统以及眼部护理产品的可持续生产呈现出良好的前景。这些细分市场不仅能带来收益来源，也能提高病患的参与度和治疗效果。整体而言，在医疗进步和消费者期望的推动下，市场充满活力，需要发展策略的灵活性和远见。相关人员必须跟上技术进步、不断变化的法规和不断变化的消费者偏好，以有效解决这个新兴的健康问题。

主要市场统计
基准年[2023] 43.9亿美元
预测年份 [2024] 47.1亿美元
预测年份 [2030] 71.6亿美元
复合年增长率（%） 7.21%

市场动态：揭示快速发展的干眼症市场的关键市场洞察

供需的动态交互作用正在改变干眼症市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 干眼症盛行率增加
    • 提高干眼诊断和治疗意识
    • 世界老年人口的增加
  • 市场限制因素
    • 严格的监管流程
  • 市场机会
    • 新技术开发
    • 加大研发投入
  • 市场问题
    • 产品召回增加

波特五力：驾驭干眼症市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解干眼症市场的外在影响

外部宏观环境因素在塑造干眼症市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解干眼症市场的竞争格局

干眼症市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：干眼症市场供应商的绩效评估

FPNV 定位矩阵是评估干眼症市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：制定干眼症市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，干眼症市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 干眼症增加
      • 提高疾病诊断和治疗意识
      • 世界各地人口老化仍在持续
    • 抑制因素
      • 严格的监管流程
    • 机会
      • 新技术开发
      • 加大研发投入
    • 任务
      • 产品召回增加
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章干眼症市场：依药品分类

  • 介绍
  • 发炎药
  • 自体血清眼药水
  • 润滑眼药水

第七章干眼症市场：副产品

  • 介绍
  • 眼药膏
  • 凝胶
  • 水滴
  • 液体擦拭巾

第八章北美和南美干眼症市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太干眼症市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲干眼症市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • AFT Pharmaceuticals
  • Akorn Operating Company LLC
  • Alcon Vision LLC
  • Bausch & Lomb Pvt Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Mitotech SA
  • Nicox SA
  • Novartis AG
  • Otsuka Holdings Co
  • Prestige Consumer Healthcare
  • Santen Pharmaceutical Co.ltd
  • Sentiss Pharma Pvt. Ltd
  • Sun Pharmaceutical Industries Ltd
Product Code: MRR-4348D129FA98

The Dry Eye Syndrome Market was valued at USD 4.39 billion in 2023, expected to reach USD 4.71 billion in 2024, and is projected to grow at a CAGR of 7.21%, to USD 7.16 billion by 2030.

Dry Eye Syndrome (DES) is a multifactorial disease characterized by a deficiency in the quantity or quality of tears, leading to inflammation and damage to the ocular surface. The market for Dry Eye Syndrome encompasses diagnostic approaches, pharmaceuticals, devices, and alternative therapies aimed at alleviating symptoms and improving the quality of life for patients. With an increasing global prevalence, driven largely by ageing populations, lifestyle changes, and prolonged digital screen exposure, the necessity for effective management options grows ever more critical. Primary applications and end-uses range from artificial tears and prescription medications to medical devices like punctal plugs and procedural solutions, catering to both consumer and clinical settings. Key growth factors include rising public awareness about eye health, advancements in diagnostic technologies, and a surge in regulatory approvals for novel treatments. The latest opportunities lie in leveraging telehealth for remote diagnosis and care, developing personalized medicine approaches, and expanding markets in emerging regions with underdiagnosed populations. Successfully capitalizing on these requires investments in R&D, collaboration with tech companies for innovative delivery mechanisms, and strategic pricing models for broader access. Despite its potential, the market faces challenges, such as stringent regulatory requirements, substantial research costs, and side effect management associated with new treatments. Additionally, market saturation in developed countries and patient non-compliance pose significant obstacles. For businesses seeking innovation, exploring non-invasive diagnostic tools, AI-driven patient management systems, and sustainable production of eye-care products offer lucrative prospects. These areas promise not just revenue streams but also enhanced patient engagement and outcomes. Overall, the market is highly dynamic, driven by both medical advancements and consumer expectations, necessitating agility and foresight in development strategies. To thrive, stakeholders must stay abreast of technological progress, evolving regulations, and shifting consumer preferences to effectively address this burgeoning health concern.

KEY MARKET STATISTICS
Base Year [2023] USD 4.39 billion
Estimated Year [2024] USD 4.71 billion
Forecast Year [2030] USD 7.16 billion
CAGR (%) 7.21%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dry Eye Syndrome Market

The Dry Eye Syndrome Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of dry eye diseases
    • Growing awareness regarding diagnosis and treatment of the disease
    • Rising geriatric population across the world
  • Market Restraints
    • Stringent regulatory process
  • Market Opportunities
    • Development of novel technologies
    • Increase in R&D investment
  • Market Challenges
    • Increase in product recall

Porter's Five Forces: A Strategic Tool for Navigating the Dry Eye Syndrome Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dry Eye Syndrome Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dry Eye Syndrome Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dry Eye Syndrome Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dry Eye Syndrome Market

A detailed market share analysis in the Dry Eye Syndrome Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dry Eye Syndrome Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dry Eye Syndrome Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Dry Eye Syndrome Market

A strategic analysis of the Dry Eye Syndrome Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dry Eye Syndrome Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AFT Pharmaceuticals, Akorn Operating Company LLC, Alcon Vision LLC, Bausch & Lomb Pvt Ltd., GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Mitotech S.A., Nicox S.A., Novartis AG, Otsuka Holdings Co, Prestige Consumer Healthcare, Santen Pharmaceutical Co.ltd, Sentiss Pharma Pvt. Ltd, and Sun Pharmaceutical Industries Ltd.

Market Segmentation & Coverage

This research report categorizes the Dry Eye Syndrome Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug, market is studied across Anti-inflammatory Drugs, Autologous Serum Eye Drops, and Lubricant Eye Drops.
  • Based on Product, market is studied across Eye Ointment, Gel, Liquid Drops, and Liquid Wipes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of dry eye diseases
      • 5.1.1.2. Growing awareness regarding diagnosis and treatment of the disease
      • 5.1.1.3. Rising geriatric population across the world
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory process
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of novel technologies
      • 5.1.3.2. Increase in R&D investment
    • 5.1.4. Challenges
      • 5.1.4.1. Increase in product recall
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Dry Eye Syndrome Market, by Drug

  • 6.1. Introduction
  • 6.2. Anti-inflammatory Drugs
  • 6.3. Autologous Serum Eye Drops
  • 6.4. Lubricant Eye Drops

7. Dry Eye Syndrome Market, by Product

  • 7.1. Introduction
  • 7.2. Eye Ointment
  • 7.3. Gel
  • 7.4. Liquid Drops
  • 7.5. Liquid Wipes

8. Americas Dry Eye Syndrome Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Dry Eye Syndrome Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Dry Eye Syndrome Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. AFT Pharmaceuticals
  • 3. Akorn Operating Company LLC
  • 4. Alcon Vision LLC
  • 5. Bausch & Lomb Pvt Ltd.
  • 6. GlaxoSmithKline PLC
  • 7. Johnson & Johnson Services, Inc.
  • 8. Mitotech S.A.
  • 9. Nicox S.A.
  • 10. Novartis AG
  • 11. Otsuka Holdings Co
  • 12. Prestige Consumer Healthcare
  • 13. Santen Pharmaceutical Co.ltd
  • 14. Sentiss Pharma Pvt. Ltd
  • 15. Sun Pharmaceutical Industries Ltd

LIST OF FIGURES

  • FIGURE 1. DRY EYE SYNDROME MARKET RESEARCH PROCESS
  • FIGURE 2. DRY EYE SYNDROME MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRY EYE SYNDROME MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. DRY EYE SYNDROME MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. DRY EYE SYNDROME MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRY EYE SYNDROME MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRY EYE SYNDROME MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRY EYE SYNDROME MARKET DYNAMICS
  • TABLE 7. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY AUTOLOGOUS SERUM EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY LUBRICANT EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY EYE OINTMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY LIQUID DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY LIQUID WIPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. DRY EYE SYNDROME MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. DRY EYE SYNDROME MARKET, FPNV POSITIONING MATRIX, 2023